Targeting of the central nervous system by Listeria monocytogenes

被引:131
|
作者
Disson, Olivier [1 ,2 ,3 ]
Lecuit, Marc [1 ,2 ,3 ,4 ]
机构
[1] Inst Pasteur, French Natl Reference Ctr, Microbes & Host Barriers Grp, Paris, France
[2] Inst Pasteur, WHO Collaborating Ctr Listeria, Paris, France
[3] INSERM, U604, Paris, France
[4] Univ Paris 05, Hop Necker Enfants Malad, Ctr Infectiol Necker Pasteur, Paris, France
基金
欧洲研究理事会;
关键词
MICROVASCULAR ENDOTHELIAL-CELLS; BRAIN-STEM ENCEPHALITIS; BACTERIAL-MENINGITIS; CLINICAL FINDINGS; VIRULENCE FACTOR; DENDRITIC CELLS; UNITED-STATES; INFECTION; RHOMBENCEPHALITIS; INVASION;
D O I
10.4161/viru.19586
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among bacteria that reach the central nervous system (CNS), Listeria monocytogenes (Lm) is one of deadliest, in human and ruminant. This facultative intracellular bacterium has the particularity to induce meningitis, meningoencephalitis and rhombencephalitis. Mechanisms by which Lm accesses the CNS remain poorly understood, but two major routes of infection have been proposed, based on clinical, in vitro and in vivo observations. A retrograde neural route is likely to occur in ruminants upon crossing of the oral epithelium, and this probably accounts for the observation that Lm induces almost exclusively rhombencephalitis in these animals. In contrast, the hematogenous route is likely the most frequent in human, in whom bacteria circulating in the blood, either free or associated with leukocytes are thought to breach the blood-brain barrier. New animal models that faithfully reproduce the hallmarks of human neurolisterisosis will allow addressing the molecular mechanisms underlying Lm ability to induce CNS disease, and improve our understanding of the pathophysiology of this deadly infection.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 50 条
  • [41] Targeting protein kinases in central nervous system disorders
    Chico, Laura K.
    Van Eldik, Linda J.
    Watterson, D. Martin
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (11) : 892 - 909
  • [42] Targeting chronic central nervous system HIV infection
    Price, Richard W.
    Swanstrom, Ronald
    ANTIVIRAL THERAPY, 2012, 17 (07) : 1227 - 1231
  • [43] Targeting protein kinases in central nervous system disorders
    Laura K. Chico
    Linda J. Van Eldik
    D. Martin Watterson
    Nature Reviews Drug Discovery, 2009, 8 : 892 - 909
  • [44] Targeting sialylation to treat central nervous system diseases
    Lunemann, Jan D.
    von Gunten, Stephan
    Neumann, Harald
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (12) : 998 - 1008
  • [45] Preferential Lentiviral Targeting of Astrocytes in the Central Nervous System
    Fassler, Michael
    Weissberg, Itai
    Levy, Nitzan
    Diaz-Griffero, Felipe
    Monsonego, Alon
    Friedman, Alon
    Taube, Ran
    PLOS ONE, 2013, 8 (10):
  • [46] Dendrimers in the context of targeting central nervous system disorders
    Palan, Forum
    Chatterjee, Bappaditya
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 73
  • [47] Snake venom toxins targeting the central nervous system
    Talukdar, Amit
    Maddhesiya, Priya
    Namsa, Nima Dondu
    Doley, Robin
    TOXIN REVIEWS, 2023, 42 (01) : 382 - 406
  • [48] Central nervous system tumor immunity generated by a recombinant Listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden -: Comments
    Piepmeier, JM
    Jensen, RL
    Walker, P
    de Tribolet, N
    NEUROSURGERY, 2006, 58 (01) : 177 - 178
  • [49] Acquired central hypoventilation following Listeria monocytogenes rhombencephalitis
    Launois, Sandrine H.
    Siyanko, Natalia
    Joyeux-Faure, Marie
    Tamisier, Renaud
    Pepin, Jean-Louis
    THORAX, 2017, 72 (08) : 763 - 765
  • [50] A role for reactive oxygen species in autophagy targeting of Listeria monocytogenes
    Lam, G. Y.
    Brumell, J. H.
    AUTOPHAGY, 2009, 5 (06) : 908 - 909